OptimizeRx.png
OptimizeRx CEO Issues Open Letter to Shareholders Ahead of Presentation at J.P. Morgan Healthcare Conference
January 04, 2023 07:30 ET | OptimizeRx Corporation
OPRX CEO Will Febbo provides business update and key industry trendsOPRX conference presentation to begin at 8:15 AM PT on January 12, 2023 ROCHESTER, Mich., Jan. 04, 2023 (GLOBE NEWSWIRE) --...
OptimizeRx.png
OptimizeRx to Participate in Upcoming Investor Conferences
November 28, 2022 09:31 ET | OptimizeRx Corporation
ROCHESTER, Mich., Nov. 28, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx.png
OptimizeRx Reports Third Quarter 2022 Financial Results
November 08, 2022 16:01 ET | OptimizeRx Corporation
Q3 Revenue of $15.1 million, down 6% year-over-year and up 8% quarter-over-quarterGross profit increased 4% year-over-year to $9.4 million as gross margins increased from 56% to 62%Generated $7.9...
OptimizeRx.png
OptimizeRx and Melinta Therapeutics Present Third Annual Innovate4Outcomes(R) Healthcare Design Thinking-Inspired Event
October 20, 2022 09:00 ET | OptimizeRx Corporation
ROCHESTER, Mich., Oct. 20, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx.png
OptimizeRx Sets Third Quarter Fiscal 2022 Conference Call for Tuesday, November 8 at 4:30 p.m. ET
October 19, 2022 16:05 ET | OptimizeRx Corporation
ROCHESTER, Mich., Oct. 19, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx.png
OptimizeRx Announces Strong Results from its use of Previously Announced AI/RWE Solution
October 11, 2022 08:00 ET | OptimizeRx Corporation
ROCHESTER, Mich., Oct. 11, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx.png
OptimizeRx Extends Exclusive Partnership with ePrescribing Leader Therapy Brands
September 20, 2022 08:00 ET | OptimizeRx Corporation
Innovative best-in-class technology solutions continue to offer HCPs a seamless prescribing experience within the EHR workflow ROCHESTER, Mich., Sept. 20, 2022 (GLOBE NEWSWIRE) -- OptimizeRx...
OptimizeRx.png
OptimizeRx to Participate in Upcoming September Conferences
September 07, 2022 08:00 ET | OptimizeRx Corporation
ROCHESTER, Mich., Sept. 07, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx.png
OptimizeRx Reports Results of Flagship Evidence-Based Physician Engagement Program
August 23, 2022 09:18 ET | OptimizeRx Corporation
Analysis finds patent-pending real-world evidence solution successful in identifying HCPs with patients at risk of non-adherence due to unexpected cost. Proactive affordability messaging key for...
OptimizeRx.png
UPDATE – OptimizeRx Reports Second Quarter 2022 Financial Results, Innovative Platform Expansions Now Extends Reach to HCPs Across Social Media and Patients at Point-of-Dispense
August 09, 2022 20:16 ET | OptimizeRx Corporation
Revenue Up 3% to $14.0 million, driven by new customer and program launchesIncrease in breadth and scope of brand deal size represents further momentum in the validation of our value...